Stock DCPH DECIPHERA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Deciphera Pharmaceuticals, Inc.

Equities

DCPH

US24344T1016

Market Closed - Nasdaq
Other stock markets
 04:00:01 2024-05-31 pm EDT 		5-day change 1st Jan Change
25.54 USD +0.04% Intraday chart for Deciphera Pharmaceuticals, Inc. +0.12% +58.34%
May. 10 Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 01 North American Morning Briefing : Traders Wait for -2- DJ

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Deciphera Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
DECIPHERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Deciphera Pharmaceuticals, Inc. - DCPH
North American Morning Briefing : Traders Wait for -2-
Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26
Leerink Downgrades Deciphera Pharmaceuticals to Market Perform, Price Target at $25.60
JMP Downgrades Deciphera Pharmaceuticals to Market Perform
North American Morning Briefing : More Earnings -2-
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc. - DCPH
US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week
Sector Update: Health Care Stocks Edge Higher Late Afternoon
Top Midday Gainers
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading
Sector Update: Health Care
JonesTrading Downgrades Deciphera Pharmaceuticals to Hold From Buy, Adjusts Price Target to $25.60 From $16
Deciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO Pharmaceutical
Jefferies Downgrades Deciphera Pharmaceuticals to Hold From Buy, Trims Price Target to $25.60 From $26
Shareholder Alert: Ademi LLP investigates whether Deciphera Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with ONO Pharmaceutical Co.
Deciphera Shares Hit 2-Year High After $2.4 Billion Buyout Offer From ONO Pharma
Deciphera Pharmaceuticals to Be Acquired by ONO Pharmaceutical in $2.4 Billion Deal
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DCPH Stock
  4. News Deciphera Pharmaceuticals, Inc.
  5. Other languages